Navigation Links
Bionovo to Present on Novel Female-Specific Drugs for Obesity at the 20th Annual Meeting of the North American Menopause Society
Date:9/24/2009

EMERYVILLE, Calif., Sept. 24 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI) today announced that Dr. Elise Saunier, a Research Scientist at Bionovo, will present the results of a study on the effects of two plant-derived, tissue-selective estrogen receptor alpha (ERa) modulators (TSERaM) for obesity at the 20th Annual Meeting of the North American Menopause Society (NAMS) in San Diego on Friday, October 2nd.

For most women, the menopausal transition results in a 10-15 pound weight gain and a redistribution of fat to the abdomen. This can increase the risk of developing metabolic syndrome, which can lead to the development of cardiovascular disease and type 2 diabetes. Though estrogens can reduce total body fat, specifically intra-abdominal and intrapelvic fat, in postmenopausal women, their use is associated with an increased risk of breast and uterine cancer because the estrogens currently used in hormone therapy are not tissue-selective. Dr. Saunier will present studies with a new class of plant-derived estrogens which act as tissue-selective ERa modulators that decrease weight in mice without stimulating the growth of breast and uterine tissue.

In this study, ovariectomized female mice, mimicking menopause, were placed on a high fat diet for one month prior to initiation of treatment. While the untreated mice continued to gain weight, the mice administered with estrogens or the plant-derived TSERaMs lost weight. While estrogens had positive effects on the body fat mass, they significantly increased the size of the mammary gland and uterus. In contrast, the same tissues in the plant-derived TSERaM-treated mice closely resembled those of the untreated mice. These findings suggest that the development of botanically-derived, tissue-selective ERa modulators could result
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
2. Bionovo Announces Proposed Public Offering of Common Stock
3. Bionovo to Present at the Biotechnology Industry Organization (BIO) Investor Forum
4. Bionovo Announces the Pricing of Public Offering of Shares of Common Stock
5. Bionovo Announces Third Quarter 2007 Financial Results
6. Bionovo to Present at Bank of Montreals 2007 Focus on Healthcare Conference
7. George Butler Joins Bionovos Board of Directors
8. Louis Drapeau Joins Bionovos Board of Directors
9. Bionovo Identifies and Describes ER-beta Selective Compounds for the Treatment of Vaginal Dryness
10. Bionovo to Present Recent Findings of BN107 and BN108, Its Anticancer Agents, at the American Association of Cancer Research
11. Bionovo Reports First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2012)... have taken a step toward overcoming a ... that could bring optical advances including ultrapowerful ... researchers have shown how to create the ... previously required, said Alexandra Boltasseva, a Purdue ... engineering. , Using the metals is impractical ...
(Date:5/15/2012)...  OrbusNeich today announced that 12-month follow-up data from ... involving the use of the company,s Combo Dual Therapy ... ® paclitaxel-eluting stent. The data were presented by ... Lukaskrankenhaus in Neuss, Germany, at EuroPCR 2012. ... driven target lesion failure (TLF) rate was 8.9% for ...
(Date:5/15/2012)... -- Cardium Therapeutics (NYSE Amex: CXM ... first quarter ended March 31, 2012, and other ... In addition to the announcement ... its goals for 2012, which were outlined in ... advance commercialization of its new Excellagen® advanced, physician-use ...
(Date:5/15/2012)... Butamax™ Advanced Biofuels, LLC announced ... Trademark Office (USPTO) has granted Butamax Patent ... highly efficient engineered pathway for producing isobutanol ... novel microorganisms have been designed using advanced ... (Logo: http://photos.prnewswire.com/prnh/20120209/MM50763LOGO ) ...
Breaking Biology Technology:New 'metamaterial' practical for optical advances 2New 'metamaterial' practical for optical advances 3OrbusNeich's Combo Dual Therapy Stent™ Demonstrates Favorable Clinical and Safety Outcomes at 12-Month Follow-Up 2OrbusNeich's Combo Dual Therapy Stent™ Demonstrates Favorable Clinical and Safety Outcomes at 12-Month Follow-Up 3OrbusNeich's Combo Dual Therapy Stent™ Demonstrates Favorable Clinical and Safety Outcomes at 12-Month Follow-Up 4Cardium Presents First Quarter 2012 Financial Results and Recent Developments 2Cardium Presents First Quarter 2012 Financial Results and Recent Developments 3Cardium Presents First Quarter 2012 Financial Results and Recent Developments 4Cardium Presents First Quarter 2012 Financial Results and Recent Developments 5Cardium Presents First Quarter 2012 Financial Results and Recent Developments 6Cardium Presents First Quarter 2012 Financial Results and Recent Developments 7Cardium Presents First Quarter 2012 Financial Results and Recent Developments 8Cardium Presents First Quarter 2012 Financial Results and Recent Developments 9Cardium Presents First Quarter 2012 Financial Results and Recent Developments 10Cardium Presents First Quarter 2012 Financial Results and Recent Developments 11Butamax Granted Core Patent for Making Biobutanol and Distillers Grains; Offers Producers Efficient, Low-Cost Production of Biobutanol 2
... an economic environment where many healthcare providers are ... patients are thriving with help from InstaMed. ... and platform, Prime Health Network has increased patient ... while also improving the patient experience at each ...
... biotechnology company delivering breakthrough therapies in central nervous system ... participating at two upcoming healthcare investor conferences. Dr. Steve ... 2nd Annual BIO Venture Conference on April 1 at ... Boston, MA. On April 9 at 11:30 a.m. PDT, ...
... Shire plc (LSE: SHP, NASDAQ:, SHPGY ), the ... Accounts in respect of the year ended December 31, ... announced unaudited full,year 2008 results, prepared in accordance with ... announcement on February 19,2009. , ...
Other Biology Technology:Prime Health Network and Its Patients Thrive in Tough Economic Times on the InstaMed Network 2Prime Health Network and Its Patients Thrive in Tough Economic Times on the InstaMed Network 3Accera, Inc. to Present at Upcoming Investor Conferences 2Publication of Shire plc's Annual Report 2008 2Publication of Shire plc's Annual Report 2008 3Publication of Shire plc's Annual Report 2008 4Publication of Shire plc's Annual Report 2008 5Publication of Shire plc's Annual Report 2008 6Publication of Shire plc's Annual Report 2008 7Publication of Shire plc's Annual Report 2008 8Publication of Shire plc's Annual Report 2008 9Publication of Shire plc's Annual Report 2008 10Publication of Shire plc's Annual Report 2008 11Publication of Shire plc's Annual Report 2008 12Publication of Shire plc's Annual Report 2008 13Publication of Shire plc's Annual Report 2008 14Publication of Shire plc's Annual Report 2008 15Publication of Shire plc's Annual Report 2008 16Publication of Shire plc's Annual Report 2008 17Publication of Shire plc's Annual Report 2008 18Publication of Shire plc's Annual Report 2008 19Publication of Shire plc's Annual Report 2008 20Publication of Shire plc's Annual Report 2008 21Publication of Shire plc's Annual Report 2008 22Publication of Shire plc's Annual Report 2008 23Publication of Shire plc's Annual Report 2008 24Publication of Shire plc's Annual Report 2008 25Publication of Shire plc's Annual Report 2008 26Publication of Shire plc's Annual Report 2008 27Publication of Shire plc's Annual Report 2008 28Publication of Shire plc's Annual Report 2008 29Publication of Shire plc's Annual Report 2008 30Publication of Shire plc's Annual Report 2008 31Publication of Shire plc's Annual Report 2008 32Publication of Shire plc's Annual Report 2008 33
(Date:5/21/2012)... team of scientists from the National University of Singapore,s ... discovered how a drug-led compound a compound that ... can deprive cancer cells of energy and stop them ... named BPTES. , This is the first time ... drug-lead compound suppresses tumour formation. , Building on ...
(Date:5/21/2012)... , , , , , ... , , , , , ... thanks to breakthrough research by CSIRO researchers who have supercharged safflower to produce increased amounts... , , ... , , , , , ... , , , , , , , , ...
(Date:5/20/2012)... melody, the male songbird uses a trial-and-error process to mimic ... over again, hundreds of times a day, making subtle changes ... finch, this rigorous training process begins around the age of ... he becomes sexually mature and ready to use his song ... brain must receive and process large quantities of information about ...
Breaking Biology News(10 mins):Novel discovery by NUS scientists paves the way for more effective treatment of cancers 2Supercharged safflower 2Supercharged safflower 3Supercharged safflower 4Songbirds' learning hub in brain offers insight into motor control 2Songbirds' learning hub in brain offers insight into motor control 3Luminex Corporation Reports Second Quarter 2011 Results 19401 1Luminex Corporation Reports Second Quarter 2011 Results 19401 2Luminex Corporation Reports Second Quarter 2011 Results 19401 3Luminex Corporation Reports Second Quarter 2011 Results 19401 4Luminex Corporation Reports Second Quarter 2011 Results 19401 5Luminex Corporation Reports Second Quarter 2011 Results 19401 6Luminex Corporation Reports Second Quarter 2011 Results 19401 7Luminex Corporation Reports Second Quarter 2011 Results 19401 8Luminex Corporation Reports Second Quarter 2011 Results 19401 9NeurogesX Inc Secures 2420 Million Debt Facility 19398 1NeurogesX Inc Secures 2420 Million Debt Facility 19398 2NeurogesX Inc Secures 2420 Million Debt Facility 19398 3NeurogesX Inc Secures 2420 Million Debt Facility 19398 4As Heart Failure Worsens Word Recall May Suffer Too 84250 1
... flavanols, the unique compounds found naturally in cocoa, may ... research published in the Neuropsychiatric Disease and Treatment journal. ... flow could impact cognitive behavior, offering future potential for ... a scientific study of healthy, older adults ages 59 ...
... entrepreneurial geneticist Craig Venter sailed around the world on ... ambitious project to use genetics to understand invisible ecological ... jumble of mystery DNA fragments belonging to thousands of ... University of Washington scientist has studied lake mud, which ...
... the sweeping destruction of the 1918 flu pandemic, researchers at ... to the virus from elderly survivors of the original ... long-lasting immunity to such viruses, these antibodies could be effective ... the 1918 flu breaks out in the future. , ...
Other Biology News:Researchers link cocoa flavanols to improved brain blood flow 2Researchers link cocoa flavanols to improved brain blood flow 3Cataloguing invisible life: Microbe genome emerges from lake sediment 2Cataloguing invisible life: Microbe genome emerges from lake sediment 31918 flu antibodies resurrected from elderly survivors 2
... Agencourt offers single pass sequencing ... service is fueled by our high ... 20 million Phred20 bases per day. ... single pass sequencing customers are rapid ...
GLP-compliant, CLIA-certified DNA sequencing service. ASQ and SQA certified quality assurance staff. Auditors welcome....
...
... calibration, and validation (MCV) plate ... plate used for hands-free startup, ... using the Bio-Plex suspension array ... for use with Bio-Plex Manager ...
Biology Products: